On 23rd June 2016 the UK voted to leave the European Union ("Brexit"). The Prime Minister subsequently announced an intention to serve notice of withdrawal under Article 50 of the Treaty on European Union by the end of March 2017. Based on Article 50, the EU Treaties shall cease to apply to the UK:
- from the date of entry into force of the withdrawal agreement that the UK negotiates with the Union, acting through the Council; or
- more likely, two years after the UK has notified the European Council of its intention to withdraw, unless the European Council, in agreement with the UK, unanimously decides to extend this period.
The current expectation is that the whole of the two year period will be needed to negotiate the exit provisions. Therefore, in practice, the Brexit date cannot be before 2019, i.e. March 2019 if notice is given in March 2017.
This briefing note advises readers on the immediate considerations and anticipates how a Brexit will impact on the IP/IT market which has been governed by so many EU Regulations and Directives in the past (albeit not exclusively) that intricately bound the UK to the EU.
The implications of Brexit are currently very uncertain and will, to a large extent, be determined by the model that would be adopted and the terms of any international agreements negotiated.
Relationship with EU law
IP laws are harmonised to a large extent across Europe, and much of the UK legislative framework in this field is currently composed of directly effective EU Regulations and transposed EU Directives. Unless those EU Regulations relevant to IP and life sciences (especially pharmaceuticals) are transposed into English or Scottish law, a regulatory vacuum may be created.
In October 2016, the Prime Minister proposed a "Great Repeal Bill". Following the UK's departure from the EU, this Bill would end the 1972 European Communities Act (ECA), which gives EU law primacy over UK law. All enactments previously in force in the UK under EU law would subsequently be reinstated. MPs would then go through each law on a piecemeal basis and amend or repeal them as necessary based upon national interests. This would facilitate a smooth transition with all EU laws, including the relevant IP Regulations and Directives remaining in force. However, the UK would still no longer be a member of the EU, which would affect the unitary character afforded to IP rights. The UK will have to negotiate an agreement with the EU to address this, but for now, until the UK actually leaves the EU, UK rights holders can continue to enforce their IP in the EU.
Implications of the Brexit
Some implications of the Brexit will apply to organisations in the same way whether they are based in the UK, in the EU or elsewhere in the world. For example, the changes to unitary patents are pertinent to any company seeking pan-European patent coverage, whereas the now likely exclusion of the UK from the European Digital Single Market, will be more acutely felt in the UK. Below is a summary of some of the main implications.
The unitary patent system
One example of where the immediate impact of Brexit may be seen is that the lengthy negotiations regarding the Unified Patent and the Unified Patent Court (UPC), which have taken decades, may be undermined. An “in” vote would have potentially meant that the system was implemented in early 2017, but in the light of the Brexit vote, there is likely to be a delay in implementation.
Without being part of the EU, it is highly unlikely that the UK, whilst it will still be a signatory to the European Patent Convention and a UK patent could still be obtained via the EPC system, will be able to participate in the new UPC system, which only applies to participating EU member states. The UK may, therefore, be seen as an irritant for companies which will need to go through another hoop to seek pan-European patent protection. Further analysis may be found here.
It is likely that community rights, such as registered and unregistered community designs and EU trade marks (previously community trade marks), will no longer have effect in the UK. Ultimately the scope of any rights applied for will not include the UK, and there will be questions about what will happen to the "UK portion" of such rights obtained before Brexit. If the right in question was automatically reduced in geographical scope, its value will diminish, especially given the economic significance of the UK, which could result in the right-holder losing out commercially. Any organisations which rely on community rights will now need swiftly to respond to changes in this area.
Life Science regulation
The UK’s various Life Sciences regulatory regimes are currently intimately connected with the EU; the European Medicines Agency is based in London and a sophisticated and comprehensive pharmacovigilance system has been established around this regime. Whilst change will, no doubt, be managed to enable a smooth transition, organisations working in this sector will need to be ready to adapt now that the regulatory framework is likely to be reshaped; a a “soft Brexit” involving continued affiliation with the current system was rejected by the government so this area is particularly uncertain. Currently, Sweden, The Netherlands and Denmark are offering to host the EMA post-Brexit.
European Digital Single Market
There is a real risk that the UK will be shut off from operating in the European Digital Single Market. The drive behind the single digital market was to promote common data protection laws, provide better access to products and services at reduced costs, and generally increase adoption and acceptance of digital services. There are significant differences in the attitudes of different European countries towards the use of social and digital media marketing and, in the absence of the UK within the EU, these differences are now likely to widen and the influence of the UK will be minimal.
Brexit is not going to be a simple divorce. Now any UK legislation, which has hitherto been dependent on EU legislation, will have to be unpicked (see above for reference to “The Great Repeal Bill”). Beyond this, the key development in the IP field is the likely exclusion of the UK from pan-European rights systems. Separation presents the opportunity for the UK's laws to diverge from those of Europe, and such separation may be embraced in some areas. However, in IP, this is unlikely to happen to any significant extent given the interconnection of trade and the universal recognition that harmonisation is beneficial. Going forwards, the UK is no longer going to be able to assert the same influence on EU policy, which may undermine the position of UK-based IP and IT companies both within Europe and on the world stage (especially vis-à-vis the USA as the UK may be seen as second class without a voice in Europe) and make it a little more difficult to compete.
Given the two year period (minimum) before which Brexit will be implemented, and given the uncertainty about what the exact Brexit environment will comprise, the long term future is still unclear. Thereafter, IP owners should identify which of their rights are now likely to be affected and may need further application/registration in order to achieve maximum protection over that right.
For any queries about any matters raised in this note, or other questions about how Brexit may affect your business, please contact Sally Shorthose.
This article is part of our Brexit series